Literature DB >> 7541138

Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.

S A Thomson1, R Khanna, J Gardner, S R Burrows, B Coupar, D J Moss, A Suhrbier.   

Abstract

The epitopes recognized by CD8+ cytotoxic T lymphocytes (CTL) are generated from cytosolic proteins by proteolytic processing. The nature of the influences exerted by the sequences flanking CTL epitopes on these processing events remains controversial. Here we show that each epitope within an artificial polyepitope protein containing nine minimal CD8+ CTL epitopes in sequence was processed and presented to appropriate CTL clones. Natural flanking sequences were thus not required to direct class I proteolytic processing. In addition, unnatural flanking sequences containing other CTL epitopes did not interfere with processing. The ability of every CTL epitope to be effectively processed from a protein containing only CTL epitopes is likely to find application in the construction of recombinant polyepitope CTL vaccines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541138      PMCID: PMC41598          DOI: 10.1073/pnas.92.13.5845

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Peptide selection by class I molecules of the major histocompatibility complex.

Authors:  T Elliott; M Smith; P Driscoll; A McMichael
Journal:  Curr Biol       Date:  1993-12-01       Impact factor: 10.834

2.  Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein.

Authors:  M Del Val; H J Schlicht; T Ruppert; M J Reddehase; U H Koszinowski
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

3.  Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation.

Authors:  F Momburg; V Ortiz-Navarrete; J Neefjes; E Goulmy; Y van de Wal; H Spits; S J Powis; G W Butcher; J C Howard; P Walden
Journal:  Nature       Date:  1992-11-12       Impact factor: 49.962

4.  Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes.

Authors:  M Gaczynska; K L Rock; A L Goldberg
Journal:  Nature       Date:  1993-09-16       Impact factor: 49.962

5.  MHC-linked LMP gene products specifically alter peptidase activities of the proteasome.

Authors:  J Driscoll; M G Brown; D Finley; J J Monaco
Journal:  Nature       Date:  1993-09-16       Impact factor: 49.962

6.  Multiple-cloning-site plasmids for the rapid construction of recombinant poxviruses.

Authors:  D B Boyle; B E Coupar; G W Both
Journal:  Gene       Date:  1985       Impact factor: 3.688

7.  Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone.

Authors:  R P Johnson; A Trocha; T M Buchanan; B D Walker
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

8.  Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides.

Authors:  L R Dick; C Aldrich; S C Jameson; C R Moomaw; B C Pramanik; C K Doyle; G N DeMartino; M J Bevan; J M Forman; C A Slaughter
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

9.  Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.

Authors:  R Khanna; S R Burrows; M G Kurilla; C A Jacob; I S Misko; T B Sculley; E Kieff; D J Moss
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

10.  Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the hemagglutinin translation product.

Authors:  Y S Hahn; V L Braciale; T J Braciale
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  26 in total

1.  Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.

Authors:  C Fayolle; A Osickova; R Osicka; T Henry; M J Rojas; M F Saron; P Sebo; C Leclerc
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 2.  The immunology of Epstein-Barr virus infection.

Authors:  D J Moss; S R Burrows; S L Silins; I Misko; R Khanna
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

3.  DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination.

Authors:  F Rodriguez; L L An; S Harkins; J Zhang; M Yokoyama; G Widera; J T Fuller; C Kincaid; I L Campbell; J L Whitton
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen.

Authors:  L L An; J L Whitton
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  Generating DNA sequences encoding tandem peptide repeats suitable for expression and immunological application.

Authors:  Hongwei Hou; Zhiqian Zhang; Wei Zhao; Jinyan Hou
Journal:  World J Microbiol Biotechnol       Date:  2012-02-22       Impact factor: 3.312

6.  Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages.

Authors:  M L Linn; L Mateo; J Gardner; A Suhrbier
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 7.  INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect.

Authors:  Alberto A Chiappori; Hatem Soliman; William E Janssen; Scott J Antonia; Dmitry I Gabrilovich
Journal:  Expert Opin Biol Ther       Date:  2010-06       Impact factor: 4.388

8.  Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine.

Authors:  Y P Shi; S E Hasnain; J B Sacci; B P Holloway; H Fujioka; N Kumar; R Wohlhueter; S L Hoffman; W E Collins; A A Lal
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 9.  TAA polyepitope DNA-based vaccines: a potential tool for cancer therapy.

Authors:  Roberto Bei; Antonio Scardino
Journal:  J Biomed Biotechnol       Date:  2010-06-17

10.  Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis.

Authors:  Suzanne L Elliott; Andreas Suhrbier; John J Miles; Greg Lawrence; Stephanie J Pye; Thuy T Le; Andrew Rosenstengel; Tam Nguyen; Anthony Allworth; Scott R Burrows; John Cox; David Pye; Denis J Moss; Mandvi Bharadwaj
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.